# A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients

> **NCT00986128** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 32 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** topiramate
- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00986128
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986128, "A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00986128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*